Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27584730.
- Also identified by DOI 10.1172/JCI84418 and PMC identifier 5004954.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent underlying Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. This human gammaherpesvirus was discovered in 1994 by Drs. Yuan Chang and Patrick Moore. Today, there are over five thousand publications on KSHV and its associated malignancies. In this article, we review recent and ongoing developments in the KSHV field, including molecular mechanisms of KSHV pathogenesis, clinical aspects of KSHV-associated diseases, and current treatments for cancers associated with this virus.
Medical subject headings
- Cell Transformation, Neoplastic
- Herpesvirus 8, Human
- Sarcoma, Kaposi